ИСТИНА	Войти в систему Регистрация
	Интеллектуальная Система Тематического Исследования НАукометрических данных
	Главная Поиск Статистика О проекте Помощь

---

Journal of Clinical Oncologyжурнал

Статьи, опубликованные в журнале

• • 2024 Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Ou
  • Rastogi Priya, O'Shaughnessy Joyce, Martin Miguel, Boyle Frances, Cortes Javier, Rugo Hope S., Goetz Matthew P., Hamilton Erika P., Huang Chiun-Sheng, Senkus Elzbieta, Tryakin Alexey, Cicin Irfan, Testa Laura, Neven Patrick, Huober Jens, Shao Zhimin, Wei Ran, André Valérie, Munoz Maria, San Antonio Belen, Shahir Ashwin, Harbeck Nadia, Johnston Stephen
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States) DOI
• • 2024 Comparison of adjuvant targeted and anti-PD1 immunotherapy in BRAF-mutated stage III cutaneous melanoma: Retrospective, single center cohort study
  • Akhmetianova Angelina, Orlova Kristina V., Nazarova Valery V., Baryshnikov Kirill A., Samoylenko Igor, Ivanilov Kirill, Demidov Lev V.
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 42, № 16_suppl, с. e21558-e21558 DOI
• • 2024 First-line therapy for metastatic uveal melanoma: Experience from a single reference center
  • Nazarova Valery V., Magomedova Zakhra R., Orlova Kristina V., Unguryan Vladimir, Romanov Denis, Yarovaya Vera, Yarovoy Andrey, Trofimova Oxana, Demidov Lev V.
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 42, № 16_suppl, с. e21514-e21514 DOI
• • 2024 Giredestrant for Estrogen Receptor–Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study
  • Ganshina I., Martín Miguel, Lim Elgene, Chavez-MacGregor Mariana, Bardia Aditya, Wu Jiong, Zhang Qingyuan, Nowecki Zbigniew, Cruz Felipe Melo, Safin Rustem, Kim Sung-Bae, Schem Christian, Montero Alberto J., Khan Sarah, Bandyopadhyay Reeti, Moore Heather M., Shivhare Mahesh, Patre Monika, Martinalbo Jorge, Roncoroni Laura, Pérez-Moreno Pablo Diego, Sohn Joohyuk, Aguil G., Alfie M., Caceres V., Lerzo G., Ostoich S., Boyle F., Lim E., Martin H., Oakman C., Cruz F.M., Franke F.A., Mattar A., Silva E.H., Tiscoski K., Chen W., Li W, Tong Z., Wang J., Wang S., Wang X., Wu J., Wu X., Yang J., Zhang Q., Emde T.O., Gaffunder G., Hielscher C., Lux M., Schem C., Welslau M., Schumacher C., Kuchuk I., Peretz T., Ryvo L., Yerushalmi R., Chae H., Chae Y.S., Im S.A., Kim H.J., Kim J.H., Kim S.B., Lee J.E., Park Y.H., Sohn J., Jarząb M., Nowaczyk M., Nowecki Z., Pienkowski T., Wojtukiewicz M., Wysocki P., Fomin E., Kislov N., Kopp M., Kovalenko N., Makarova Y., Matrosova M., Orlova R., Poltoratsky A., Safin R., Zukov R., Wong A., Yap Y.S., Coccia-Portugal M., Fourie N., Khanyile R., Schoeman L., Chao T.C., Chen S.T., Chung W.P., Feng Y.H., Lin Y.C., Dejthevaporn T., Parinyanitikul N., Sathitruangsak C., Somwangprasert A., Tienchaianada P., Alacacioglu A., Algin E., Cabuk D., Demir C., Demirci U., Erdem D., Gündüz Ş., Yildirim M.E., Khan S., Schmid P., Sandri I., Oikonomidou O., Ansari T., Konstantis A., Hrybach S., Krochkin A., Lipetska O., Osinskii D., Hrybach S., Krochkin A., Lipetska O., Osinskii D., Andersen J.C., Cairo M., Cobb P., Konala V., McCune S.L., Montero A.J., Patt D.A., Sanchez-Rivera I., Strain S., Wendell K.
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 42, № 18, с. 2149-2160 DOI
• • 2024 Giredestrant for Estrogen Receptor–Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study
  • Ganshina I., Martín Miguel, Lim Elgene, Chavez-MacGregor Mariana, Bardia Aditya, Wu Jiong, Zhang Qingyuan, Nowecki Zbigniew, Cruz Felipe Melo, Safin Rustem, Kim Sung-Bae, Schem Christian, Montero Alberto J., Khan Sarah, Bandyopadhyay Reeti, Moore Heather M., Shivhare Mahesh, Patre Monika, Martinalbo Jorge, Roncoroni Laura, Pérez-Moreno Pablo Diego, Sohn Joohyuk, Aguil G., Alfie M., Caceres V., Lerzo G., Ostoich S., Boyle F., Lim E., Martin H., Oakman C., Cruz F.M., Franke F.A., Mattar A., Silva E.H., Tiscoski K., Chen W., Li W, Tong Z., Wang J., Wang S., Wang X., Wu J., Wu X., Yang J., Zhang Q., Emde T.O., Gaffunder G., Hielscher C., Lux M., Schem C., Welslau M., Schumacher C., Kuchuk I., Peretz T., Ryvo L., Yerushalmi R., Chae H., Chae Y.S., Im S.A., Kim H.J., Kim J.H., Kim S.B., Lee J.E., Park Y.H., Sohn J., Jarząb M., Nowaczyk M., Nowecki Z., Pienkowski T., Wojtukiewicz M., Wysocki P., Fomin E., Kislov N., Kopp M., Kovalenko N., Makarova Y., Matrosova M., Orlova R., Poltoratsky A., Safin R., Zukov R., Wong A., Yap Y.S., Coccia-Portugal M., Fourie N., Khanyile R., Schoeman L., Chao T.C., Chen S.T., Chung W.P., Feng Y.H., Lin Y.C., Dejthevaporn T., Parinyanitikul N., Sathitruangsak C., Somwangprasert A., Tienchaianada P., Alacacioglu A., Algin E., Cabuk D., Demir C., Demirci U., Erdem D., Gündüz Ş., Yildirim M.E., Khan S., Schmid P., Sandri I., Oikonomidou O., Ansari T., Konstantis A., Hrybach S., Krochkin A., Lipetska O., Osinskii D., Hrybach S., Krochkin A., Lipetska O., Osinskii D., Andersen J.C., Cairo M., Cobb P., Konala V., McCune S.L., Montero A.J., Patt D.A., Sanchez-Rivera I., Strain S., Wendell K.
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 42, № 18, с. 2149-2160 DOI
• • 2024 Lenvatinib plus pembrolizumab (L+P) vs sunitinib (S) in advanced renal cell carcinoma (aRCC): Patterns of progression and subsequent therapy in the CLEAR trial
  • Grünwald Viktor, Motzer Robert J., Keizman Daniel, Bedke Jens, Schmidinger Manuela, Staehler Michael D., Matveev Vsevolod B., George Saby, Hutson Thomas E., Vaishampayan Ulka N., Merchan Jaime R., Eto Masatoshi, Rha Sun Young, Waddell Tom, Sabbatini Roberto, Barthelemy Philippe, Burgents Joseph E., Ren Min, Brown Ian, CHOUEIRI Toni K.
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 42, № 16_suppl, с. 4524-4524 DOI
• • 2024 Microsatellite instability (MSI) in patients with gastric cancer (GC) and correlation with PD-L1 expression
  • Henian Sun, Nered Sergey, Tryakin Alexey, Abgaryan Mikael, Artamonova Elena, Stroganova Anna, Stilidi Ivan
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 42, № 3_suppl, с. 389-389 DOI
• • 2024 Mucosal melanoma treatment patterns and outcomes in real clinical practice: Single institution experience
  • Samoylenko Igor, Stroganova Anna, Orlova Kristina V., Kuzmenko Angelina, Martynova Margarita, Kogai Ekaterina, Nazarova Valery V., Petenko Natalia N., Demidov Lev V.
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 42, № 16_suppl, с. e21571-e21571 DOI
• • 2024 Mucosal melanoma treatment patterns and outcomes in real clinical practice: Single institution experience
  • Samoylenko Igor, Stroganova Anna, Orlova Kristina V., Kuzmenko Angelina, Martynova Margarita, Kogai Ekaterina, Nazarova Valery V., Petenko Natalia N., Demidov Lev V.
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 42, № 16_suppl, с. e21571-e21571 DOI
• • 2024 Multicenter clinical trial of DNA markers for non-invasive differential diagnosis of benign and malignant melanocytic lesions
  • Samoylenko Igor, Zaretsky Andrew R., Chudakova Lidia V., Drozd Oleg V., Garanina Oksana E., Shlivko Irena L., Yargunin Sergey A., Zinovev Grigory, Baryshnikov Kirill A., Sinelnikov Igor, Mikhaylova Irina N., Vishnevskaya Yana, Orlova Kristina V., Demidov Lev V.
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 42, № 16_suppl, с. e21550-e21550 DOI
• 
  • 2024 Plasma Kidney Injury Molecule-1 for Preoperative Prediction of Renal Cell Carcinoma Versus Benign Renal Masses, and Association With Clinical Outcomes
  • Xu Wenxin, Gaborieau Valerie, Niman Samuel M., Mukeria Anush, Liu Xiaowen, Maremanda Krishna P., Takakura Ayumi, Zaridze David, Freedman Matthew L., Xie Wanling, McDermott David F., Choueiri Toni K., Catalano Paul J., Sabbisetti Venkata, Bonventre Joseph V., Pierorazio Phillip M., Singla Nirmish, Brennan Paul, Bhatt Rupal S.
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 42, № 22, с. 2691-2701 DOI
• • 2024 The outcomes of atezolizumab therapy in combination with carboplatin and etoposide for small-cell lung cancer
  • Kamishov Sergey, Tillyashaykhov Mirzagaleb, Yusupbekov Abrorjon, Niyozova Shakhnoza Khamoydinovna, Balenkov Oleg, Izrailbekova Kamila, Kobilov Odiljon, Lipartiya Meri, Rafiev Dilshod
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 42, № 16_suppl, с. e20115-e20115 DOI
• • 2023 Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non–Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial
  • Herbst Roy S., Wu Yi-Long, John Thomas, Grohe Christian, Majem Margarita, Wang Jie, Kato Terufumi, Goldman Jonathan W., Laktionov Konstantin
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 41, № 8 DOI
• • 2023 CNS Efficacy of Osimertinib With or Without Chemotherapy in Epidermal Growth Factor Receptor–Mutated Advanced Non–Small-Cell Lung Cancer
  • Janne Pasi A., Kunihiko Kobayashi David Planchard, Cheng Ying, Lee Chee Khoon, Valdiviezo Natalia, Laktionov Konstantin
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States) DOI
• • 2023 CNS Efficacy of Osimertinib With or Without Chemotherapy in Epidermal Growth Factor Receptor–Mutated Advanced Non–Small-Cell Lung Cancer
  • Jänne Pasi A., Planchard David, Kobayashi Kunihiko, Cheng Ying, Lee Chee Khoon, Valdiviezo Natalia, Laktionov Konstantin
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States) DOI
• • 2023 Defendor special: Interim analysis of TCHP with primary empegfilgrastim prophylaxis (long-acting G-CSF) for treatment outcomes in early HER2+ breast cancer
  • Zhukova Lyudmila, Ibragimova Tansylu, Ganshina Inna, Filonenko Daria, Sorokina Irina
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 41, № 16_suppl, с. e12586-e12586 DOI
• 
  • 2023 Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study
  • ML Johnson, Cho BC, Luft A., Alatorre-Alexander J., Geater SL, Laktionov K., Kim SW, Ursol G., Hussein M., Lim FL, Yang CT, Araujo LH, Saito H., Reinmuth N., Shi X., Poole L., Peters S., Garon EB, Mok T.
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 41, № 6, с. 1213-1227 DOI
• • 2023 Imbalanced censoring as a bias in evaluation of randomized controlled trials: A simulation-based study
  • Rumyantsev Alexey, Tyulyandina Alexandra, Tjulandin Sergei
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 41, № 16_suppl, с. e13606-e13606 DOI
• 
  • 2023 Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer
  • Tachibana Isamu, Adra Nabil, Nicolai Nicola, Ho Matthew, Tryakin Alexey, Fedyanin Mikhail, in collaboration with the EAU-YAU Penile, Testis Cancer Working Group
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 41, № 34, с. 5296-5305 DOI
• 
  • 2023 Smoking Cessation After Diagnosis of Kidney Cancer Is Associated With Reduced Risk of Mortality and Cancer Progression: A Prospective Cohort Study
  • Sheikh Mahdi, Mukeriya Anush, Zahed Hana, Feng Xiaoshuang, Robbins Hilary A., Shangina Oxana, Matveev Vsevolod, Brennan Paul, Zaridze David
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 41, № 15, с. 2747-2755 DOI
• 
  • 2023 Surgery in Metastatic Seminoma: Negative Trial Should Be Treated as Negative
  • Rumyantsev Alexey A., Tyulyandina Alexandra S., Tryakin Alexey A., Fedyanin Mikhail Y., Tjulandin Sergey A.
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 41, № 33, с. 5202-5203 DOI
• • 2023 The polymorphic markers of the <i>XRCC1</i>, <i>ERCC5</i>, <i>TP53</i>, <i>CDKN1A1</i> genes and the survival of triple negative breast cancer patients after platinum-based chemotherapy
  • Kolyadina Irina Vladimirovna, Zavarykina Tatiana, Lomskova Polina, Gordeeva Olga, Kapralova Maria, Ganshina Inna, Khokhlova Svetlana Victorovna
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 41, № 16_suppl, с. e12556-e12556 DOI
• • 2022 A first-in-human phase 1b study of a novel allosteric extracellular FGFR2 inhibitor alofanib in patients with refractory metastatic gastric cancer
  • Tjulandin Sergei, Statsenko Galina, Artamonova Elena, Vladimirova Liubov Yu, Besova Natalia, Mochalova Anastasia, Rykov Ivan, Moiseyenko Vladimir, Utyashev Igor A., Iugai Sergei, Kazey Vasily, Raskin Grigory, Dragun Nadezhda, Reznikov Dmitry, Gavrilova Evgenia, Tsimafeyeu Ilya
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 40, № 4_suppl, с. 304-304 DOI
• • 2022 Antimetastatic effect of benzimidazole derivative on the model of melanoma B16 in the experiment
  • Kurbanova L.Z., Shevchenko Nataliya, Verenikina Ekaterina V., Komarova Ekaterina Fedorovna, Filatova Elena V., Khomutenko Irina A., Goncharova Anna S., Lukbanova Ekaterina A., Khodakova D.V., Galina A.V., Mindar Maria V., Zaikina Ekaterina V., Komarova Elizaveta
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 40, № 16_suppl, с. e21562-e21562 DOI
• • 2022 Antitumor effectiveness of combination therapy with platinum and hybrid organotin compound on the Lewis epidermoid carcinoma model with metronomic administration
  • Kotieva I.M., Dodokhova M.A., Safronenko A.V., Alkhuseyn-Kulyaginova M.S., Milaeva E.R., Nikitin E.A., Shpakovsky D.B., Kotieva E.М., Kotieva V.М., Starostin S.I.
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 40, № 16 suppl., с. e15080-e15080 DOI